theblood
PrivateLast Round
Seed
May 10, 2024
Total Funding Raised
$1.06M
Company Overview
theblood is a FemTech company that provides an at-home test kit for non-invasive menstrual blood analysis to help women monitor their health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, D2C Brands, Subscription Commerce, Healthcare Analytics
Business Model
B2C
Customer Profile
Subscription SaaS, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
theblood Comparables
Compare theblood with similar companies based on industry and business-model similarity.
theblood Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 10, 2024 | ||||
| Pre Seed | Mar 14, 2023 |
theblood Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RoX Health | Pre Seed |
theblood Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about theblood's valuation, stock price, and market status.